NOVADAQ TECH
PharmaNOVADAQ TECH is a pharmaceutical company focused on Oncology, Immunology. Key products include SPY AGENT GREEN KIT.
NOVADAQ TECH's Key Drugs
NOVADAQ TECH's core commercial portfolio centers on SPY AGENT GREEN KIT, spanning Oncology and Immunology — its most strategically important drugs approved in the last 15 years.
NOVADAQ TECH's Recent FDA Approvals
New NDA/BLA approvals for NOVADAQ TECH over the last two years — novel drugs only, excluding generics and label supplements.
NOVADAQ TECH's Therapeutic Areas
NOVADAQ TECH's approved drugs and pipeline span 2 therapeutic areas, led by Oncology and Immunology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
NOVADAQ TECH's Top Competitors
NOVADAQ TECH's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Novartis, and AbbVie. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
NOVADAQ TECH Pipeline Snapshot
NOVADAQ TECH has 3 active clinical programs from ClinicalTrials.gov — 1 Phase 3, 0 Phase 2 and 2 Phase 1.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • SPY AGENT GREEN KIT leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Oncology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2018-11-21
- Latest
- 2023-06-05
- Applications
- 1